Coated-platelets retain amyloid precursor protein on their surface

被引:41
|
作者
Prodan, CI
Szasz, R
Vincent, AS
Ross, ED
Dale, GL
机构
[1] Univ Oklahoma, Sch Med, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA
[3] Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Vet Adm Med Ctr, Oklahoma City, OK 73104 USA
关键词
coated-platelet; thrombin; convulxin; collagen; amyloid precursor protein; Alzheimer's disease;
D O I
10.1080/09537100500181913
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Coated-Platelets are a subset of platelets produced by dual-agonist activation with collagen plus thrombin and are characterized by strong retention of several procoagulant, alpha-granule proteins on the cell surface. In this report we demonstrate that coated-platelets also retain full-length amyloid precursor protein (APP) on their surface in contrast to the cleavage of APP in platelets activated with a single agonist. In addition, western blot analysis indicated that APP is derivatized during coated-platelet synthesis. We subsequently measured coated-platelet production in patients with Alzheimer's disease (AD). Twenty-two AD patients showed a wide distribution of coated-platelet values; however the least impaired AD patients produced coated-platelets at a level significantly above that of aged controls (41.0 +/- 9.9 vs. 28.7 +/- 11.4%; mean +/- 1SD; p = 0.017). These findings suggest that coated-platelets may be a model of aberrant APP processing in early AD patients.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 50 条
  • [21] THE AMYLOID PRECURSOR PROTEIN OF ALZHEIMERS-DISEASE IS RELEASED BY HUMAN PLATELETS
    BUSH, AI
    MARTINS, RN
    RUMBLE, B
    MOIR, R
    FULLER, S
    MILWARD, E
    CURRIE, J
    AMES, D
    WEIDEMANN, A
    FISCHER, P
    MULTHAUP, G
    BEYREUTHER, K
    MASTERS, CL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (26) : 15977 - 15983
  • [22] Coated-Platelets Predict Stroke at 30 days in Patients with Transient Ischemic Attack
    Kirkpatrick, Angelia
    Vincent, Andrea
    Dale, George
    Prodan, Calin
    STROKE, 2015, 46
  • [23] Coated-platelets are higher in amnestic versus nonamnestic patients with mild cognitive impairment
    Prodan, Calin I.
    Ross, Elliott D.
    Vincent, Andrea S.
    Dale, George L.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (03): : 259 - 261
  • [24] Tetraspanin CD9 is required for microparticle release from coated-platelets
    Dale, George L.
    Remenyi, Gyula
    Friese, Paul
    PLATELETS, 2009, 20 (06) : 361 - 366
  • [25] Calmodulin regulates the non-amyloidogenic metabolism of amyloid precursor protein in platelets
    Canobbio, I.
    Catricala, S.
    Balduini, C.
    Torti, M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (03): : 500 - 506
  • [26] Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets
    Evin, G
    Zhu, AQ
    Holsinger, RMD
    Masters, CL
    Li, QX
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (03) : 386 - 392
  • [27] Effects of oxidative stress on amyloid precursor protein processing in rat and human platelets
    Ehrlich, Daniela
    Hochstrasser, Tanja
    Humpel, Christian
    PLATELETS, 2013, 24 (01) : 26 - 36
  • [28] Possible role of calpain in normal processing of β-amyloid precursor protein in human platelets
    Chen, M
    Durr, J
    Fernandez, HL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (01) : 170 - 175
  • [29] Molecular insights into aneurysmal subarachnoid hemorrhage and cerebral vasospasm from analysis of coated-platelets
    Ding, Dale
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 338 (1-2) : 236 - 236
  • [30] The amyloid precursor protein: beyond amyloid
    Zheng, Hui
    Koo, Edward H.
    MOLECULAR NEURODEGENERATION, 2006, 1 (1)